HOUSTON, TX. Medical device firm Procyrion, Inc., today announced that Steven Oldham has been appointed to its board of directors where he will represent Series A stockholders and help the management team execute against an aggressive plan to commercialize the company’s novel medical device.
Procyrion is developing Aortix™, the first catheter-deployed circulatory assist device intended for long-term use in the treatment of chronic heart failure.
Oldham is currently Vice President, Treasurer and Investor Relations of McDermott International, a leading engineering, procurement, construction and installation company focused on executing complex offshore oil and gas projects worldwide. He brings more than 19 years of financial experience to the Procyrion Board of Directors including investor relations, capital structure and corporate liquidity management, bank and rating agency relationships, investment analysis, and foreign exchange risk mitigation.
“I am happy to have the opportunity to work with Procyrion’s talented and entrepreneurial management team to support their efforts to commercialize their exciting technology,” said Oldham. “I look forward to working with the business team and maintaining a close relationship among the Board, management and Series A investors.”
“Procyrion is in an important phase of development and Mr. Oldham’s extensive corporate finance and investor relations expertise will add valuable perspective as we bring the Aortix™ heart pump to market. Mr. Oldham has already demonstrated that his business acumen and governance will be a great addition to the company,” said Benjamin A. Hertzog, PhD, Procyrion’s president and CEO.
Prior to being named McDermott International’s vice president in 2012, Oldham served as Vice President and Treasurer of Pride International, a global oil and gas offshore drilling contractor. He began his career as a research analyst for Bank of America and Salomon Brothers.
Oldham joins current board members Leo Linbeck, President and CEO of Aquinas Companies, LLC; Dr. Reynolds Delgado, Procyrion, Inc. founder and Medical Director of Mechanical Support Devices in Heart Failure at Texas Heart Institute; and Benjamin A. Hertzog, President and CEO of Procyrion, Inc.
ABOUT PROCYRION:
Houston-based medical device firm Procyrion, Inc. is developing the first catheter-deployed, intra-aortic pump for ambulatory use. The device is designed to rest and heal the heart by reducing afterload while simultaneously improving blood flow to vital organs. This groundbreaking cardiology tool, conceived by cardiologist Dr. Reynolds M. Delgado, III, medical director of Mechanical Support Devices in Heart Failure at the Texas Heart Institute, is expected to provide a minimally invasive treatment option for millions of chronic heart failure patients. For more information, visit www.procyrion.com or call 713.579.9227.
Company Name: Procyrion, Inc.
Contact Person: Anna Drake
Email:Send Email
Phone: 713.510.0500
Address:3900 Essex Lane Suite 575
City: Houston
State: TX
Country: United States
Website: www.procyrion.com
Source: www.abnewswire.com
0 comments:
Post a Comment